The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ionis Pharmaceuticals, Inc(NASDAQ:IONS) 
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis...
Website: http://www.ionispharma.com
Founded: 1989
Full Time Employees: 817
Sector: Healthcare
Industry: Biotechnology
Ionis Pharmaceuticals Days Payable Outstanding ttm (DPO)
Ionis Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Ionis Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Ionis Pharmaceuticals Op Cashflow Per Share ttm
Ionis Pharmaceuticals Free Cashflow Per Share ttm
Ionis Pharmaceuticals Cash Per Share ttm
Ionis Pharmaceuticals P/S ratio ttm
Ionis Pharmaceuticals (GAAP) P/E ratio ttm
Ionis Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.